Many human tumor cells are resistant to growth inhibition by TGF beta 1. Re
sistance may be caused by mutations in TGF beta receptors or in other compo
nents of the TGF beta signal transduction systems, or by knockout of the re
tinoblastoma (Rb) gene, which in fibroblasts converts cellular response to
TGF beta 1 from growth inhibition to growth stimulation. Our earlier studie
s showed such a switch in response to TGF beta 1 occurred in 45% of colon c
ancers but without deletion of Rb. We now show that insulin-like growth fac
tor binding protein 3 (IGFBP-3) mediates the TGF beta 1-induced proliferati
on of 3 metastatic or highly aggressive colon carcinoma cell lines. TGF bet
a 1 increases IGFBP-3 abundance while phosphorothiolated antisense oligonuc
leotides to IGFBP-3 block the growth-promoting effect of TGF beta 1 in each
of 3 lines. IGFBP-3 induces carcinoma cell growth in a dose-dependent and
time-dependent manner in vitro. IGFBP-3 may confer a selective growth advan
tage on tumor cells in vivo because levels of mature IGFBP-3 were elevated
at least 2-fold in 7 of 10 resected colon cancers compared with adjacent no
rmal tissue. Int. J. Cancer 87:373-378, 2000. (C) 2000 Wiley-Liss, Inc.